Zoetis Inc (NYSE:ZTS)
| 166.14 BATS BZX Real-Time Price As of 3:17pm ET |  +3.13 / +1.92%Today’s Change | 124.15 Today|||52-Week Range 187.82 | +13.37% Year-to-Date |
Latest ZTS News | Press Releases
| Kristin Peck Sells 13,000 Shares of Zoetis Inc (ZTS) May 27 / GuruFocus News - Paid Partner Content | Zoetis Inc CEO Kristin Peck Sells 13,000 Shares May 26 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 163.01 |
| Today’s open | 163.01 |
| Day’s range | 161.62 - 166.19 |
| Volume | 1,216,683 |
| Average volume (3 months) | 1,982,670 |
| Market cap | $76.1B |
Data as of 3:17pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | +4.99% |
| Earnings growth (this year) | +10.70% |
| Earnings growth (next 5 years) | +10.91% |
| Revenue growth (last year) | +3.91% |
| P/E ratio | 37.6 |
| Price/Sales | 8.53 |
| Price/Book | 18.77 |
Competitors
| ---- | ||
| REGNRegeneron Pharmaceut... | -1.50 | -0.20% |
| GSKGlaxoSmithKline | +0.20 | +0.60% |
| GLAXFGlaxoSmithKline | -0.06 | -0.36% |
Data as of 3:17pm ET, 06/01/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | $1.32 |
| Annual revenue (last year) | $8.1B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 26.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
